-
In this issue: Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions.
-
Goldberger and colleagues at the University of Michigan sought to determine the variation in duration of cardiopulmonary resuscitation (CPR) attempts following in-hospital cardiac arrest among different institutions across the United States.
-
Kumar et al set out to describe the cost of ICU telemedicine programs (tele-ICU). They had two objectives: to systematically review the existing literature reporting costs of tele-ICU programs and to provide cost figures for tele-ICU implementation in a Veterans Health Administration (VHA) hospital network.
-
-
-
Much of the recent attention to the high cost of health care has focused on opposing political viewpoints. Less attention has been given to an equally important issue: How do health care delivery organizations reliably deliver high-value health care and, by doing this, ensure optimal patient outcomes?
-
In this contribution from Germany, Schulz and colleagues provide an annotated, referenced table of therapeutic, toxic, and potentially fatal blood concentrations of nearly 1000 drugs and other xenobiotics (substances foreign to the body that may be ingested or otherwise reach the circulation).
-
The use of non-steroidal anti-inflammatory drugs (NSAIDs) early after myocardial infarction (MI) has been shown to increase the risk of death or recurrent MI, but little is known about the long-term risks. Thus, this group from Denmark evaluated their national database and identified more than 99,000 patients who survived 30 days after discharge following their first MI.
-
In this single-center, prospective study, median duration of antibiotics for community-acquired pneumonia (CAP) decreased from 10 to 7 days with an antibiotic stewardship program that included education and prospective feedback to the managing team.
-
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.